Global pharmaceutical company Cephalon Inc. has signed an agreement with Alba Therapeutics regarding a potential celiac disease drug.
01/28/2011Half of patients studied reported symptom relief within 4 weeks.
12/10/2010New center will support development of new therapeutics, which bodes well for celiac treatment research.
Newer Posts 1 2 … 4 5
Opt-in to stay up-to-date on the latest news.
Yes, I want to advance research No, I'd prefer not to
